Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma

Laryngoscope

Volumn 122, Issue 7, 2012, Pages 1558-1565

  Duray, Anaëlle ^a   Descamps, Géraldine ^a   Decaestecker, Christine ^b   Remmelink, Myriam ^d   Sirtaine, Nicolas ^b   Lechien, Jérôme ^a   Ernoux Neufcoeur, Perle ^a   Bletard, Noëlla ^c   Somja, Joan ^c   Depuydt, Christophe E ^e   Delvenne, Philippe ^c   Saussez, Sven ^a,f  

^a UNIVERSITY OF MONS   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d ERASME HOSPITAL   (Belgium)

^e Laboratory for Clinical Pathology and Molecular Biology (Labo Lokeren Campus Riatol)   (Belgium)

^f SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

carcinoma; Human papillomavirus; oral cavity; polymerase chain reaction; typing

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PARAFFIN; PROTEIN P16; PROTEIN P53; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 67; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84862862715     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23298     Document Type: Article

References (56)

1. Kreimer AR, Clifford GM, Boyle P, Franceschi S,. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-475.
2. Filleul O, Preillon J, Crompot E, Lechien J, Saussez S,. Incidence of head and neck cancers in Belgium: comparison with worldwide and french data. Bull Cancer 2011; 98: 1173-1183.
3. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.
4. Sturgis EM, Cinciripini PM,. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007; 110: 1429-1435.
5. Duray A, Descamps G, Arafa M, et al. High incidence of high-risk HPV in benign and malignant lesions of the larynx. Int J Oncol 2011; 39: 51-59.
6. Dahlstrand H, Nasman A, Romanitan M, Lindquist D, Ramqvist T, Dalianis T,. Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer. Anticancer Res 2008; 28: 1133-1138.
7. Rosenquist K, Wennerberg J, Annertz K, et al. Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors. Acta Otolaryngol 2007; 127: 980-987.
8. Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007; 120: 1731-1738.
9. Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008; 26: 3128-3137.
10. Hennessey PT, Westra WH, Califano JA,. Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res 2009; 88: 300-306.
11. Kozomara R, Jovic N, Magic Z, Brankovic-Magic M, Minic V,. p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival. J Craniomaxillofac Surg 2005; 33: 342-348.
12. Koskinen WJ, Chen RW, Leivo I, et al. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 2003; 107: 401-406.
13. Brandwein M, Zeitlin J, Nuovo GJ, et al. HPV detection using "hot start" polymerase chain reaction in patients with oral cancer: a clinicopathological study of 64 patients. Mod Pathol 1994; 7: 720-727.
14. Pintos J, Franco EL, Black MJ, Bergeron J, Arella M,. Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract. Cancer 1999; 85: 1903-1909.
15. Simonato LE, Garcia JF, Sundefeld ML, Mattar NJ, Veronese LA, Miyahara GI,. Detection of HPV in mouth floor squamous cell carcinoma and its correlation with clinicopathologic variables, risk factors and survival. J Oral Pathol Med 2008; 37: 593-598.
16. Spandidos DA,. Oncogenes and tumor suppressor genes as paradigms in oncogenesis. J BUON 2007; 12 (Suppl 1): S9-S12.
17. Neufcoeur PE, Arafa M, Delvenne P, Saussez S,. Involvement of human papillomavirus in upper aero-digestive tracts cancers. Bull Cancer 2009; 96: 941-950.
18. Almadori G, Cadoni G, Cattani P, et al. Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma. Clin Cancer Res 2001; 7: 3988-3993.
19. Ernoux-Neufcoeur P, Arafa M, Decaestecker C, et al. Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma. J Cancer Res Clin Oncol 2011; 137: 173-181.
20. Pim D, Collins M, Banks L,. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 1992; 7: 27-32.
21. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-747.
22. Depuydt CE, Benoy IH, Bailleul EJ, Vandepitte J, Vereecken AJ, Bogers JJ,. Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi. Cytopathology 2006; 17: 374-381.
23. Depuydt CE, Boulet GA, Horvath CA, Benoy IH, Vereecken AJ, Bogers JJ,. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med 2007; 11: 881-891.
24. Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P, Depuydt C,. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium. Cancer Epidemiol Biomarkers Prev 2009; 18: 321-330.
25. Saussez S, Decaestecker C, Lorfevre F, et al. Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. Histopathology 2008; 52: 483-493.
26. Syrjanen K, Syrjanen S, Lamberg M, Pyrhonen S, Nuutinen J,. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 1983; 12: 418-424.
27. Larson DA, Derkay CS,. Epidemiology of recurrent respiratory papillomatosis. APMIS 2010; 118: 450-454.
28. Miller CS, Johnstone BM,. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91: 622-635.
29. Nemes JA, Deli L, Nemes Z, Marton IJ,. Expression of p16 (INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 344-352.
30. Friedrich RE, Sperber C, Jakel T, Roser K, Loning T,. Basaloid lesions of oral squamous epithelial cells and their association with HPV infection and P16 expression. Anticancer Res 2010; 30: 1605-1612.
31. El-Mofty SK, Patil S,. Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 339-345.
32. Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM,. Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 2001; 125: 1-9.
33. Boscolo-Rizzo P, Da Mosto MC, Fuson R, Frayle-Salamanca H, Trevisan R, Del Mistro A,. HPV-16 E6 L83V variant in squamous cell carcinomas of the upper aerodigestive tract. J Cancer Res Clin Oncol 2009; 135: 559-566.
34. Gallo A, Degener AM, Pagliuca G, et al. Detection of human papillomavirus and adenovirus in benign and malignant lesions of the larynx. Otolaryngol Head Neck Surg 2009; 141: 276-281.
35. Garcia-Milian R, Hernandez H, Panade L, et al. Detection and typing of human papillomavirus DNA in benign and malignant tumours of laryngeal epithelium. Acta Otolaryngol 1998; 118: 754-758.
36. Lindeberg H, Krogdahl A,. Laryngeal cancer and human papillomavirus: HPV is absent in the majority of laryngeal carcinomas. Cancer Lett 1999; 146: 9-13.
37. Zaravinos A, Mammas IN, Sourvinos G, Spandidos DA,. Molecular detection methods of human papillomavirus (HPV). Int J Biol Markers 2009; 24: 215-222.
38. Termine N, Panzarella V, Falaschini S, et al. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol 2008; 19: 1681-1690.
39. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100: 407-420.
40. Smith EM, Rubenstein LM, Haugen TH, Hamsikova E, Turek LP,. Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers. Cancer Causes Control 2010; 21: 1369-1378.
41. Ragin CC, Taioli E,. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007; 121: 1813-1820.
42. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM,. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 2001; 92: 805-813.
43. Sedaghat AR, Zhang Z, Begum S, et al. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope 2009; 19: 1542-1549.
44. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
45. Hansson BG, Rosenquist K, Antonsson A, et al. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol 2005; 125: 1337-1344.
46. Clayman GL, Stewart MG, Weber RS, el-Naggar AK, Grimm EA,. Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival. Arch Otolaryngol 1994; 120: 743-748.
47. Morshed K,. Association between human papillomavirus infection and laryngeal squamous cell carcinoma. J Med Virol 2010; 82: 1017-1023.
48. Duray A, Demoulin S, Hubert P, Delvenne P, Saussez S,. Immune suppression in head and neck cancers: a review. Clin Dev Immunol 2010; 2010: 701657.
49. Kreimer AR, Alberg AJ, Daniel R, et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004; 189: 686-698.
50. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001; 285: 2995-3002.
51. Tung YC, Lin KH, Chu PY, Hsu CC, Kuo WR,. Detection of human papillomavirus and Epstein Barr virus DNA in nasopharyngeal carcinoma by polymerase chain reaction. Kaohsiung J Med Sci 1999; 15: 256-262.
52. Lepique AP, Daghastanli KR, Cuccovia IM, Villa LL,. HPV16 tumor associated macrophages suppress antitumor T cell responses. Clin Cancer Res 2009; 15: 4391-4400.
53. Begum S, Gillison ML, Ansari-Lari MA, et al. Detection for papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 2003; 9: 6469-6475.
54. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996; 56: 3630-3633.
55. Klussmann JP, Gultekin E, Weissenborn SJ, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003; 162: 747-753.
56. Fury MG, Drobnjak M, Sima CS, et al. Tissue microarray evidence of association between p16 and phosphorylated eIF4E in tonsillar squamous cell carcinoma. Head Neck 2011; 33: 1340-1345.